Open RFP

Extramural Biomedical Research and Development

Description: Extramural biomedical research and development.

Buyer: U.S. Army Medical Research Acquisition Activity (USAMRAA)
Federal · MD, US
Released: Jul 27, 2023
Closes: Aug 1, 2028(698 days left)

Files

Original attachments and procurement documents tied to this bid.

Federal RFP files are for Starbridge customers only.

You can request RFP files from all other buyer types for free on this site.

Similar active RFPs

Adjacent opportunities open for bidding right now.

Defense Health Agency (DHA)
FederalVA
Posted
Jul 23, 2025
Closes
Aug 1, 2028
Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Extramural biomedical and human performance research and development.
Defense Health Agency (DHA)
FederalVA
Posted
Jul 23, 2025
Closes
Aug 1, 2028
Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1
Extramural biomedical and human performance research and development.
The House of Representatives
FederalDC
Posted
Sep 28, 2023
Closes
Sep 25, 2028
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
To catalyze innovation in advanced research development (R&D), manufacturing, procurement of medical countermeasures (MCMs). These lifesaving MCMS are needed to protect people during public health emergencies from threats such as chemical, biological, radiological, nuclear (CBRN) incidents (whether accidental OR intentional), pandemic influenza, COVID-19, other emerging infectious diseases. BARDA works closely with interagency partners through the public health emergency medical countermeasures enterprise (PHEMCE) to ensure a coordinated, whole-of-government approach to MCM preparedness response.
Department of Health and Human Services
FederalDC
Posted
Sep 26, 2023
Closes
Sep 25, 2028
Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Advanced research and development (R&D) of medical countermeasures (MCMs) for chemical, biological, radiological, and nuclear (CBRN) agents, pandemic influenza, and emerging infectious diseases.

See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.

See your top 10 accounts